Alexandra Blackman

Alexandra Blackman

Auto-generated profile, based on publicly available information

Alexandra Blackman

Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina. 1

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2024 in Cancer Research Communications
Verified
Journal Article
Open access
PDF file
ABAlexandra Blackman
Alexandra Blackman
ARAmy C. Rees
Amy C. Rees
RBRobert R. Bowers
Robert R. Bowers
CJChristian M. Jones
Christian M. Jones
SVSilvia G. Vaena
Silvia G. Vaena
JDJoe R. Delaney
Joe R. Delaney
Genetically engineered mouse models (GEMM) have fundamentally changed how ovarian cancer etiology, early detection, and treatment are understood. MYC, an oncogene, is amongst the most amplified genes in high-grade serous ovarian cancer (HGSOC), but it has not previously been utilized to drive HGSOC GEMMs. We coupled Myc and dominant-negative mutant p53-R270H with a fallopian tube epithelium (FTE)-specific promoter Ovgp1 to generate a new GEMM of HGSOC. Female mice developed lethal cancer at an average of 14.5 months. Histopathologic examination of mice revealed HGSOC characteristics, including nuclear p53 and nuclear MYC in clusters of cells within the FTE and ovarian surface epithelium. Unexpectedly, nuclear p53 and MYC clustered cell expression was also identified in the uterine luminal epithelium, possibly from intraepithelial metastasis from the FTE. Extracted tumor cells exhibited strong loss of heterozygosity at the p53 locus, leaving the mutant allele. Copy-number alterations in these cancer cells were prevalent, disrupting a large fraction of genes. Transcriptome profiles most closely matched human HGSOC and serous endometrial cancer. Taken together, these results demonstrate that the Myc and Trp53-R270H transgenes were able to recapitulate many phenotypic hallmarks of HGSOC through the utilization of strictly human-mimetic genetic hallmarks of HGSOC. This new mouse model enables further exploration of ovarian cancer pathogenesis, particularly in the 50% of HGSOC which lack homology-directed repair mutations. Histologic and transcriptomic findings are consistent with the hypothesis that uterine serous cancer may originate from the FTE. Significance: Mouse models using transgenes which generate spontaneous cancers are essential tools to examine the etiology of human diseases. Here, the first Myc-driven spontaneous model is described as a valid HGSOC model. Surprisingly, aspects of uterine serous carcinoma were also observed in this model.


26 September 2024
Verified
Other
Open access
ABAlexandra Blackman
Alexandra Blackman
ARAmy C. Rees
Amy C. Rees
RBRobert R. Bowers
Robert R. Bowers
CJChristian M. Jones
Christian M. Jones
SVSilvia G. Vaena
Silvia G. Vaena
JDJoe R. Delaney
Joe R. Delaney
Molecular histology of the fallopian fimbriae. A, A WT mouse at 12 months of age showing little p53 or MYC staining in the FTE. B, OvTrpMyc fallopian tube at 15 months of age, F135, exhibiting p53 and MYC staining within the FTE. C, An OvTrpMyc mouse at 12 months of age, with vacuolated fallopian fimbriae–positive for p53 and MYC. D, An OvTrpMyc mouse at 15 months of age, with features resembling STIC.

26 September 2024
Verified
Other
Open access
ABAlexandra Blackman
Alexandra Blackman
ARAmy C. Rees
Amy C. Rees
RBRobert R. Bowers
Robert R. Bowers
CJChristian M. Jones
Christian M. Jones
SVSilvia G. Vaena
Silvia G. Vaena
JDJoe R. Delaney
Joe R. Delaney
CNAs, transcriptomics, and tumorigenicity of extracted OvTrpMyc tumor cells. A, Dissection diagram for ex vivo expansion. Gynecologic tract for mouse F318 is shown. B, LOH was observed by PCR of the Trp53 transgene (mutation) in isolated cells. C, Whole-genome CNA calls of tumor cells. Blue indicates copy-number loss, and red indicates copy-number gain. D, Transcriptomic profiling of OvTrpMyc cancer cells compared with human gynecologic cancer within the human CCLE. Header genes refer to mutation in p53 (green), MYC amplification (red), or CCNE1 amplification (red), shaded white if absent or gray if unknown. Nearest neighbor human cell lines comprise the cell lines shown. A2780, MDA-MB-453, and KHYG cell lines are shown as representative cell lines which have driver gene characteristics comparable with the mouse cell lines but clearly different transcriptional profiles. E, 8 × 106 F339 ROV OvTrpMyc cell line cells were injected i.p. into a young OvTrpMyc female recipient mouse. The mouse lost weight, meeting euthanasia criteria after 54 days. IHC staining of a dissected tumor attached to the intestines is shown. F, Distribution of tumors found in F318 LOV i.p. syngeneic injected mice (5 × 106 cells, 132 days) relative to a human image depiction of HGSOC metastatic spread. LOV, left ovary; ROV, right ovary; Ut, uterus.

26 September 2024
Verified
Other
Open access
PDF file
ABAlexandra Blackman
Alexandra Blackman
ARAmy C. Rees
Amy C. Rees
RBRobert R. Bowers
Robert R. Bowers
CJChristian M. Jones
Christian M. Jones
SVSilvia G. Vaena
Silvia G. Vaena
JDJoe R. Delaney
Joe R. Delaney
PAX8 staining corresponding to other immunohistochemical figures

3 April 2025
Verified
Other
Open access
ABAlexandra Blackman
Alexandra Blackman
ARAmy C. Rees
Amy C. Rees
RBRobert R. Bowers
Robert R. Bowers
CJChristian M. Jones
Christian M. Jones
SVSilvia G. Vaena
Silvia G. Vaena
JDJoe R. Delaney
Joe R. Delaney
Genetically engineered mouse models (GEMM) have fundamentally changed how ovarian cancer etiology, early detection, and treatment are understood. MYC, an oncogene, is amongst the most amplified genes in high-grade serous ovarian cancer (HGSOC), but it has not previously been utilized to drive HGSOC GEMMs. We coupled Myc and dominant-negative mutant p53-R270H with a fallopian tube epithelium (FTE)-specific promoter Ovgp1 to generate a new GEMM of HGSOC. Female mice developed lethal cancer at an average of 14.5 months. Histopathologic examination of mice revealed HGSOC characteristics, including nuclear p53 and nuclear MYC in clusters of cells within the FTE and ovarian surface epithelium. Unexpectedly, nuclear p53 and MYC clustered cell expression was also identified in the uterine luminal epithelium, possibly from intraepithelial metastasis from the FTE. Extracted tumor cells exhibited strong loss of heterozygosity at the p53 locus, leaving the mutant allele. Copy-number alterations in these cancer cells were prevalent, disrupting a large fraction of genes. Transcriptome profiles most closely matched human HGSOC and serous endometrial cancer. Taken together, these results demonstrate that the Myc and Trp53-R270H transgenes were able to recapitulate many phenotypic hallmarks of HGSOC through the utilization of strictly human-mimetic genetic hallmarks of HGSOC. This new mouse model enables further exploration of ovarian cancer pathogenesis, particularly in the 50% of HGSOC which lack homology-directed repair mutations. Histologic and transcriptomic findings are consistent with the hypothesis that uterine serous cancer may originate from the FTE.Significance:Mouse models using transgenes which generate spontaneous cancers are essential tools to examine the etiology of human diseases. Here, the first Myc-driven spontaneous model is described as a valid HGSOC model. Surprisingly, aspects of uterine serous carcinoma were also observed in this model.